These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9732906)

  • 1. Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Roig E; Orús J; Paré C; Azqueta M; Filella X; Perez-Villa F; Heras M; Sanz G
    Am J Cardiol; 1998 Sep; 82(5):688-90, A8. PubMed ID: 9732906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences of disease progression in congestive heart failure due to alcoholic as compared to idiopathic dilated cardiomyopathy.
    Prazak P; Pfisterer M; Osswald S; Buser P; Burkart F
    Eur Heart J; 1996 Feb; 17(2):251-7. PubMed ID: 8732379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives of partial left ventriculectomy in the treatment of dilated cardiomyopathy.
    Moreira LF; Stolf NA; de Lourdes Higuchi M; Bacal F; Bocchi EA; Oliveira SA
    Eur J Cardiothorac Surg; 2001 Jan; 19(1):54-60. PubMed ID: 11163561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry.
    Aleksova A; Sabbadini G; Merlo M; Pinamonti B; Barbati G; Zecchin M; Bussani R; Silvestri F; Iorio AM; Stolfo D; Dal Ferro M; Dragos AM; Meringolo G; Pyxaras S; Lo Giudice F; Perkan A; di Lenarda A; Sinagra G
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):699-705. PubMed ID: 19474760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy.
    Ramahi TM; Longo MD; Cadariu AR; Rohlfs K; Slade M; Carolan S; Vallejo E; Wackers FJ
    Eur Heart J; 2001 May; 22(10):849-56. PubMed ID: 11350094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study.
    Morales MA; Neglia D; L'Abbate A
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):778-82. PubMed ID: 18607240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group.
    Rusconi P; Wilkinson JD; Sleeper LA; Lu M; Cox GF; Towbin JA; Colan SD; Webber SA; Canter CE; Ware SM; Hsu DT; Chung WK; Jefferies JL; Cordero C; Lipshultz SE;
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid Status, Cardiac Function, and Mortality in Patients With Idiopathic Dilated Cardiomyopathy.
    Wang W; Guan H; Gerdes AM; Iervasi G; Yang Y; Tang YD
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3210-8. PubMed ID: 26052725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum levels of soluble interleukin-2 receptor, neopterin and beta-2-microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis.
    Caforio AL; Goldman JH; Baig MK; Mahon NJ; Haven AJ; Souberbielle BE; Holt DW; Dalgleish AG; McKenna WJ
    Eur J Heart Fail; 2001 Mar; 3(2):155-63. PubMed ID: 11246052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of circulating levels of interleukin-6 and tumor necrosis factor-alpha in hypertrophic cardiomyopathy and in idiopathic dilated cardiomyopathy.
    Högye M; Mándi Y; Csanády M; Sepp R; Buzás K
    Am J Cardiol; 2004 Jul; 94(2):249-51. PubMed ID: 15246916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy.
    Juillière Y; Barbier G; Feldmann L; Grentzinger A; Danchin N; Cherrier F
    Eur Heart J; 1997 Feb; 18(2):276-80. PubMed ID: 9043845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frustrating search for arrhythmia risk stratifiers in heart failure due to nonischemic cardiomyopathy: does T-wave alternans testing help?
    Verrier RL; Kumar K; Josephson ME
    J Am Coll Cardiol; 2007 Nov; 50(19):1905-6. PubMed ID: 17980259
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic Impact of Segmental Wall Motion Abnormality in Patients With Idiopathic Dilated Cardiomyopathy.
    Iida Y; Inomata T; Kaida T; Fujita T; Ikeda Y; Nabeta T; Ishii S; Koitabashi T; Takeuchi I; Ako J
    Int Heart J; 2017 Aug; 58(4):544-550. PubMed ID: 28701682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricle volume affects the result of mitral valve surgery for idiopathic dilated cardiomyopathy to treat congestive heart failure.
    Horii T; Suma H; Isomura T; Nomura F; Hoshino J
    Ann Thorac Surg; 2006 Oct; 82(4):1349-54; discussion 1354-5. PubMed ID: 16996932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial left ventriculectomy with mitral valve preservation in the treatment of patients with dilated cardiomyopathy.
    Moreira LF; Stolf NA; Bocchi EA; Bacal F; Giorgi MC; Parga JR; Jatene AD
    J Thorac Cardiovasc Surg; 1998 Apr; 115(4):800-7. PubMed ID: 9576213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma amylase levels in advanced chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy: correlation with circulating interleukin-6 activity.
    Parissis JT; Adamopoulos SN; Venetsanou KF; Karas SM; Kremastinos DT
    J Interferon Cytokine Res; 2003 Jun; 23(6):329-33. PubMed ID: 12859859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mid-term results of heart transplantation, cardiomyoplasty, and medical treatment of refractory heart failure caused by idiopathic dilated cardiomyopathy.
    Bocchi EA; Bellotti G; Moreira LF; Bacal F; de Moraes AV; Fiorelli A; Mansur A; Stolf N; Jatene A; Pileggi F
    J Heart Lung Transplant; 1996 Jul; 15(7):736-45. PubMed ID: 8820791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical outcome and reversibility of systolic dysfunction in patients with dilated cardiomyopathy due to hypertension and chronic heart failure].
    Anguita Sánchez M; Rodríguez Esteban M; Ojeda Pineda S; Ruiz Ortiz M; Romo Peña E; Mesa Rubio D; Vallés Belsué F
    Rev Esp Cardiol; 2004 Sep; 57(9):834-41. PubMed ID: 15373989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.